nach oben

Erschienen in:

2013 | OriginalPaper | Buchkapitel

28. Cellular-Type Hemoglobin-Based Oxygen Carrier as a Resuscitative Fluid for Hemorrhagic Shock: Acute and Long-Term Safety Evaluation Using Beagle Dogs

verfasst von : Tatsuhiko Ikeda, Hirohisa Horinouchi, Yoraro Izumi, Hiromi Sakai, Koichi Kobayashi

Erschienen in: Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

Verlag: Springer Berlin Heidelberg

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Hemoglobin-vesicles (HbV, d = 251 nm) are an artificial oxygen carrier encapsulating a concentrated Hb solution in polyethylene glycol-modified phospholipid vesicles (liposomes). Their safety and efficacy as artificial red blood cells and a fluid for oxygen therapeutics have been extensively studied in various rodent models. We have previously reported the efficacy of HbV as a resuscitation fluid in canine hemorrhagic shock model. However, long term safety was not yet studied. In this chapter, we report the results of efficacy and safety study in Beagle dog using hemorrhagic shock model. We observed the animals for one year. Twenty-six male beagle dogs were used. For acute study, a dog was anesthetized by 2.0–2.5 % sevoflurane and spontaneous respiration was maintained. A thermodilution catheter was introduced into pulmonary artery for measurement of cardiovascular parameters. Fifty percent of estimated blood volume was withdrawn from right femoral artery, and the shock state was stabilized for 1 h. The dogs were resuscitated either with isovolemic 5 % recombinant human serum albumin alone (rHSA) HbV suspended in rHSA (HbV/rHSA), or shed autologous blood (SAB). HbV/rHSA group showed immediate recovery of hemodynamic and blood gas parameters as did SAB, and no abnormal hypertension was observed. HbV contributed to about 34-38 % of the total delivery of oxygen and 26–29 % of total consumption of oxygen for 4 h. For chronic phase study, the beagle dogs resuscitated with HbV/rHSA or SAB were caged for up to 1 year. All dogs survived and gained weight. Results of hematological and plasma biochemical analyses and pathological examination showed no notable abnormalities except the transient accumulation of HbV in reticuloendothelial system and a release of cholesterol derived from HbV. The present results using beagle dogs reassure that HbV suspended in rHSA shows a similar resuscitative ability and safety to that of SAB.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel The Hemoglobin-Based Oxygen Carrier, HBOC-201, as a Resuscitation Fluid for Traumatic Hemorrhagic Shock: The Naval Medical Research Center Experience

Nächstes Kapitel Key Adverse Events in Recent HBOC Phase III Clinical Trials and Their Causal Relationship to Test HBOC’s

Abe H, Fujihara M, Azuma H, Ikeda H, Ikebuchi K, Takeoka S et al (2006) Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: effects on coagulation, kallikrein-kinin, and complement systems. Artif Cells Blood Substit Immobil Biotechnol 34(1):1–10CrossRef

American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies. Anesthesiol 105(1):198–208

Atoji T, Aihara M, Sakai H, Tsuchida E, Takeoka S (2006) Hemoglobin vesicles containing methemoglobin and l-tyrosine to suppress methemoglobin formation in vitro and in vivo. Bioconjug Chem 17(5):1241–1245CrossRef

Awasthi VD, Garcia D, Klipper R, Goins BA, Phillips WT (2004) Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics. J Pharmacol Exp Ther 309(1):241–248CrossRef

Azarov I, Liu C, Reynolds H, Tsekouras Z, Lee JS, Gladwin MT, Kim Shapiro DB (2011) Mechanism of slower nitric oxide uptake by red blood cells and other hemoglobin-containing vesicles. J Biol Chem 286(38):33567–33579CrossRef

Bennett GD, Kay MM (1981) Homeostatic removal of senescent murine erythrocytes by splenic macrophages. Exp Hematol 9(3):297–307

Bosman RJ, Minten J, Lu HR, Van Aken H, Flameng W (1992) Free polymerized hemoglobin versus hydroxyethyl starch in resuscitation of hypovolemic dogs. Anesth Analg 75(5):811–817

Cabrales P, Sakai H, Tsai AG, Takeoka S, Tsuchida E, Intaglietta M (2005) Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilution. Am J Physiol Heart Circ Physiol. 288(4):H1885–H1892CrossRef

Contaldo C, Plock J, Sakai H, Takeoka S, Tsuchida E, Leunig M et al (2005) New generation of hemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue. Crit Care Med 33(4):806–812CrossRef

D’Agnillo F, Alayash AI (2001) Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells. Blood 98(12):3315–3323CrossRef

Dijkstra J, van Galen M, Regts D, Scherphof G (1985) Uptake and processing of liposomal phospholipids by Kupffer cells in vitro. Eur J Biochem 148(2):391–397CrossRef

Djordjevich L, Mayoral J, Miller IF, Ivankovich AD (1987) Cardiorespiratory effects of exchange transfusions with synthetic erythrocytes in rats. Crit Care Med 15(4):318–323CrossRef

Driessen B, Jahr JS, Lurie F, Griffey SM, Gunther RA (2001) Effects of haemoglobin-based oxygen carrier hemoglobin glutamer-200 (bovine) on intestinal perfusion and oxygenation in a canine hypovolaemia model. Br J Anaesth 86(5):683–692CrossRef

Finch CA, Huebers H (1982) Perspectives in iron metabolism. N Engl J Med 306(25):1520–1528CrossRef

Goda N, Suzuki K, Naito M, Takeoka S, Tsuchida E, Ishimura Y et al (1998) Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin Invest 101(3):604–612CrossRef

Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J et al (1998) The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 187(2):113–120 discussion 20-2CrossRef

Grady JK, Chen Y, Chasteen ND, Harris DC (1989) Hydroxyl radical production during oxidative deposition of iron in ferritin. J Biol Chem 264(34):20224–20229

Hoit BD, Gabel M, Fowler NO (1991) Influence of splenectomy on hemodynamics during cardiac tamponade. Am J Physiol 261(4 Pt 2):R907–R911

Horinouchi H, Yamamoto H, Komatsu T, Huang Y, Tsuchida E, Kobayashi K (2008) Enhanced radiation response of a solid tumor with the artificial oxygen carrier ‘albumin-heme’. Cancer Sci 99(6):1274–1278CrossRef

Izumi Y, Sakai H, Kose T, Hamada K, Takeoka S, Yoshizu A, Horinouchi H, Kato R, Nishide H, Tsuchida E, Kobayashi K (1997) Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model. ASAIO J 438(49):289–297

Johnson JL, Moore EE, Offner PJ, Partrick DA, Tamura DY, Zallen G et al (2001) Resuscitation with a blood substitute abrogates pathologic post injury neutrophil cytotoxic function. J Trauma 50(3):449–455 Discussion 56CrossRef

Kansaku R, Mizuno T, Tatsumi E, Ogata Y, Ishizuka T, Taenaka Y (2008) Oxygen metabolism during cardiopulmonary bypass with hemodilution using liposome-encapsulated hemoglobin in kid goats. J Artif Organs. 11(1):24–28CrossRef

Kasper SM, Grune F, Walter M, Amr N, Erasmi H, Buzello W (1998) The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 87(2):284–291

Kitazawa M, Ohnishi Y (1982) Long term experiment of perfluorochemicals using rabbits. Virchow Arch A Pathol Anat Histhopathol 398(1):1–10

Kuipers F, Spanjer HH, Havinga R, Scherphof GL, Vonk RJ (1986) Lipoproteins and liposomes as in vivo cholesterol vehicles in the rat: preferential use of cholesterol carried by small unilamellar liposomes for the formation of muricholic acids. Biochim Biophys Acta 876(3):559–566CrossRef

Lee R, Neya K, Svizzero TA, Vlahakes GJ (1995) Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 79(1):236–242

Lehnert M, Arteel GE, Smutney OM, Conzelmann LO, Zhong Z, Thurman RG et al (2003) Dependence of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide. Shock 19(4):345–351CrossRef

Marks DH, Lynett JE, Letscher RM, TenEyck RP, Schaerle AD, Makovec GT et al (1987) Pyridoxalated polymerized stroma-free hemoglobin solution (SFHS-PP) as an oxygen-carrying fluid replacement for hemorrhagic shock in dogs. Mil Med 152(5):265–271

McDonald MC, Izumi M, Cuzzocrea S, Thiemermann C (2002) A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock. J Physiol Pharmacol 53(4 Pt 1):555–569

Mota-Filipe H, McDonald MC, Cuzzocrea S, Thiemermann C (1999) A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 12(4):255–261CrossRef

Nakai K, Sakuma I, Ohta T, Ando J, Kitabatake A, Nakazato Y et al (1998) Permeability characteristics of hemoglobin derivatives across cultured endothelial cell monolayers. J Lab Clin Med 132(4):313–319CrossRef

Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (2008) Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 299(19):2304–2312CrossRef

Nozue M, Lee I, Manning JM, Manning LR, Jain RK (1996) Oxygenation in tumors by modified hemoglobins. J Surg Oncol 62(2):109–114CrossRef

O’Connell MJ, Ward RJ, Baum H, Peters TJ (1989) Iron release from haemosiderin and ferritin by therapeutic and physiological chelators. Biochem J 260(3):903–907

Pape A, Kertscho H, Meier J, Horn O, Laout M, Steche M et al (2008) Improved short-term survival with polyethylene glycol modified hemoglobin liposomes in critical normovolemic anemia. Intensive Care Med 34(8):1534–1543CrossRef

Rudolph AS, Spielberg H, Spargo BJ, Kossovsky N (1995) Histopathologic study following administration of liposome-encapsulated hemoglobin in the normovolemic rat. J Biomed Mater Res 29(2):189–196CrossRef

Sakai H, Takeoka S, Park SI, Kose T, Nishide H, Izumi Y et al (1997) Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90 % exchange transfusion in anesthetized rats. Bioconjug Chem 8(1):23–30CrossRef

Sakai H, Hara H, Yuasa M, Tsai AG, Takeoka S, Tsuchida E et al (2000a) Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol 279(3):H908–H915

Sakai H, Yuasa M, Onuma H, Takeoka S, Tsuchida E (2000b) Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: objective comparison between cellular and acellular types. Bioconjug Chem 11(1):56–64CrossRef

Sakai H, Horinouchi H, Tomiyama K, Ikeda E, Takeoka S, Kobayashi K et al (2001) Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol 159(3):1079–1088CrossRef

Sakai H, Tomiyama K, Masada Y, Takeoka S, Horinouchi H, Kobayashi K et al (2003) Pretreatment of serum containing hemoglobin vesicles (oxygen carriers) to prevent their interference in laboratory tests. Clin Chem Lab Med 41(2):222–231

Sakai H, Masada Y, Horinouchi H, Ikeda E, Sou K, Takeoka S et al (2004a) Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days. J Pharmacol Exp Ther 311(3):874–884CrossRef

Sakai H, Horinouchi H, Masada Y, Takeoka S, Ikeda E, Takaori M et al (2004b) Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model. Biomaterials 25(18):4317–4325CrossRef

Sakai H, Masada Y, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S et al (2004c) Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 32(2):539–545CrossRef

Sakai H, Hisamoto S, Fukutomi I, Sou K, Takeoka S, Tsuchida E (2004d) Detection of lipopolysaccharide in hemoglobin-vesicles by Limulus amebocyte lysate test with kinetic-turbidimetric gel clotting analysis and pretreatment of surfactant. J Pharm Sci 93(2):310–321CrossRef

Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E (2008a) Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions. J Intern Med 263(1):4–15

Sakai H, Seishi Y, Obata Y, Takeoka S, Horinouichi H, Tsuchida E, Kobayashi k (2009) Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 Days. Shock 31(2):192--200

Sakai H, Okuda N, Takeoka S, Tsuchida E (2011) Increased viscosity of hemoglobin based oxygen carriers retards NO-binding when perfused through narrow gas-permeable tubes. Microvascular Res 81(2):169–176CrossRef

Sou K, Tsuchida E (2008) Electrostatic interactions and complement activation on the surface of phospholipid vesicle containing acidic lipids: effect of the structure of acidic groups. Biochim Biophys Acta 1778(4):1035–1041CrossRef

Sou K, Naito Y, Endo T, Takeoka S, Tsuchida E (2003) Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol Prog 19(5):1547–1552CrossRef

Sou K, Klipper R, Goins B, Tsuchida E, Phillips WT (2005) Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J Pharmacol Exp Ther 312(2):702–709CrossRef

Standl T, Burmeister MA, Horn EP, Wilhelm S, Knoefel WT, Schulte am Esch J (1998) Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br J Anaesth 80(2):189–94

Stuecklin-Utsch A, Hasan C, Bode U, Fleischhack G (2002) Pancreatic toxicity after liposomal amphotericin B. Mycoses 45(5–6):170–173CrossRef

Taguchi K, Urata Y, Anraku M, Maruyama T, Watanabe H, Sakai H, Horinouchi H, Kobayashi K, Tsuchida E, Kai T, Otagiri M (2009) Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier. Drug Metab Dispos 37(7):1456–1463CrossRef

Yamamoto M, Horinouchi H, Kobayashi K, Seishi Y, Sato N, Itoh M, Sakai H (2012) Fluid resuscitation of hemorrhagic shock with hemoglobin vesicles in Beagle dogs: pilot study. Artif Cells Blood Substit Immobil Biotechnol 40(1–2):179–195CrossRef

Yamazaki M, Aeba R, Yozu R, Kobayashi K (2006) Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats. Circulation 114(1 Supple):1220–1225

Yoshizu A, Izumi Y, Park S, Sakai H, Takeoka S, Horinouchi H et al (2004) Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintains intestinal perfusion and suppresses the increase in plasma tumor necrosis factor-alpha. ASAIO J 50(5):458–463CrossRef

Young MA, Malavalli A, Winslow N, Vandegriff KD, Winslow RM (2007) Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys. Transl Res 149(6):333–342CrossRef

Yu B, Raher MJ, Volpato GP, Bloch KD, Ichinose F, Zapol WM (2008) Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 117(15):1982–1990CrossRef

Titel: Cellular-Type Hemoglobin-Based Oxygen Carrier as a Resuscitative Fluid for Hemorrhagic Shock: Acute and Long-Term Safety Evaluation Using Beagle Dogs
verfasst von: Tatsuhiko Ikeda
Hirohisa Horinouchi
Yoraro Izumi
Hiromi Sakai
Koichi Kobayashi
Verlag: Springer Berlin Heidelberg
Buch: Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
Print ISBN: 978-3-642-40716-1

Electronic ISBN: 978-3-642-40717-8

Copyright-Jahr: 2013
DOI: https://doi.org/10.1007/978-3-642-40717-8_28

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht